Eligibility and preference of extended antithrombotic therapy for secondary prevention after an acute coronary syndrome

被引：0
|
作者：
Candeias Faria, D. [1 ]
Santos, M. [1 ]
Roque, D. [1 ]
Ferreira, J. [1 ]
Beringuilho, M. [1 ]
Augusto, J. [1 ]
机构：
[1] Hosp Prof Fernando da Fonseca EPE, Cardiol, Amadora, Portugal
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6410
引用
收藏
页码：4010 / 4010
页数：1
相关论文
共 50 条
  • [1] Eligibility for extended antithrombotic therapy for secondary prevention of acute coronary syndrome
    Faria, Daniel
    Santos, Miguel
    Baptista, Sergio Bravo
    Ferreira, Joao
    Leal, Paulo
    Farto e Abreu, Pedro
    Morais, Carlos
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2020, 39 (09) : 493 - 501
  • [2] Antithrombotic therapy after acute coronary syndrome or percutaneous coronary intervention
    Zado, Erica S.
    HEART RHYTHM, 2022, 19 (05)
  • [3] Recent advances in antithrombotic therapy after acute coronary syndrome
    Matteau, Alexis
    Bhatt, Deepak L.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (08) : 589 - 596
  • [4] Antithrombotic therapy for acute coronary syndrome
    Schaefer, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (09) : 496 - 501
  • [5] Antithrombotic therapy in acute coronary syndrome
    Chazov, EI
    Panchenko, EP
    TERAPEVTICHESKII ARKHIV, 2000, 72 (03) : 65 - 75
  • [6] Failure of secondary prevention after acute coronary syndrome
    Bouamaied, N.
    Monassier, J. P.
    DIABETES & METABOLISM, 2007, 33 : S83 - S83
  • [7] Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients
    Husted, Steen
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 263 - 277
  • [8] Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
    Millesimo, Michele
    Elia, Edoardo
    Marengo, Giorgio
    De Filippo, Ovidio
    Raposeiras-Roubin, Sergio
    Wanha, Wojciech
    Abu-Assi, Emad
    Kinnaird, Tim
    Ariza-Sole, Albert
    Liebetrau, Christoph
    Manzano-Fernandez, Sergio
    Iannaccone, Mario
    Henriques, Jose Paulo Simao
    Templin, Christian
    Wilton, Stephen B.
    Velicki, Lazar
    Xanthopoulou, Ioanna
    Correia, Luis
    Cerrato, Enrico
    Rognoni, Andrea
    Nunez-Gil, Ivan
    Song, Xiantao
    Kawaji, Tetsuma
    Quadri, Giorgio
    Huczek, Zenon
    Paz, Rafael Cobas
    Juanatey, Jose Ramon Gonzalez
    Nie, Shao-Ping
    Kawashiri, Masa-Aki
    Dominguez-Rodriguez, Alberto
    Conrotto, Federico
    D'Ascenzo, Fabrizio
    De Ferrari, Gaetano Maria
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (01) : 77 - 87
  • [9] Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
    Michele Millesimo
    Edoardo Elia
    Giorgio Marengo
    Ovidio De Filippo
    Sergio Raposeiras-Roubin
    Wojciech Wańha
    Emad Abu-Assi
    Tim Kinnaird
    Albert Ariza-Solé
    Christoph Liebetrau
    Sergio Manzano-Fernández
    Mario Iannaccone
    Jose Paulo Simao Henriques
    Christian Templin
    Stephen B. Wilton
    Lazar Velicki
    Ioanna Xanthopoulou
    Luis Correia
    Enrico Cerrato
    Andrea Rognoni
    Iván Nuñez-Gil
    Xiantao Song
    Tetsuma Kawaji
    Giorgio Quadri
    Zenon Huczek
    Rafael Cobas Paz
    José Ramón González Juanatey
    Shao-Ping Nie
    Masa-aki Kawashiri
    Alberto Dominguez-Rodriguez
    Federico Conrotto
    Fabrizio D’Ascenzo
    Gaetano Maria De Ferrari
    American Journal of Cardiovascular Drugs, 2023, 23 : 77 - 87
  • [10] Effect and safety of antithrombotic therapies for secondary prevention after acute coronary syndrome: a network meta-analysis
    Mo, Fanrui
    Lie, Juan
    Yan, Yuluan
    Wu, Weifeng
    Lai, Shayi
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3583 - 3594
12345